PCM
BSX icon

Penserra Capital Management’s Boston Scientific BSX Stock Holding History

Penserra Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5K Buy
126
+3
+2% +$163 ﹤0.01% 952
2026
Q1 		$7K Sell
123
-3
-2% -$240 ﹤0.01% 893
2025
Q4 		$12K Hold
126
– – ﹤0.01% 839
2025
Q3 		$12K Hold
126
– – ﹤0.01% 837
2025
Q2 		$13K Sell
126
-8,685
-99% -$879K ﹤0.01% 811
2025
Q1 		$888K Buy
8,811
+4,952
+128% +$499K 0.02% 480
2024
Q4 		$344K Buy
3,859
+3,733
+2,963% +$329K 0.01% 636
2024
Q3 		$10K Buy
126
+6
+5% +$473 ﹤0.01% 890
2024
Q2 		$9K Hold
120
– – ﹤0.01% 936
2024
Q1 		$8K Sell
120
-6,655
-98% -$428K ﹤0.01% 937
2023
Q4 		$390K Sell
6,775
-1,425
-17% -$76.1K 0.01% 577
2023
Q3 		$432K Sell
8,200
-1,114
-12% -$58.4K 0.01% 560
2023
Q2 		$503K Buy
9,314
+9,236
+11,841% +$482K 0.01% 519
2023
Q1 		$3K Hold
78
– – ﹤0.01% 963
2022
Q4 		$3K Buy
+78
New +$3.38K ﹤0.01% 1023
2022
Q2 		– Sell
-684
Closed -$30K – 1391
2022
Q1 		$30K Sell
684
-306
-31% -$13.3K ﹤0.01% 1135
2021
Q4 		$42K Sell
990
-192
-16% -$8.07K ﹤0.01% 1063
2021
Q3 		$51K Buy
1,182
+682
+136% +$30.2K ﹤0.01% 1045
2021
Q2 		$21K Buy
+500
New +$21K ﹤0.01% 1133
2019
Q3 		– Sell
-3,150
Closed -$135K – 863
2019
Q2 		$135K Buy
+3,150
New +$121K 0.01% 446

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Penserra Capital Management's BSX Position: Q2 2026 in Review

Penserra Capital Management increased its Boston Scientific (BSX) stake by 2.4% in Q2 2026, buying an estimated $163 and bringing the position to 126 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #952.

Penserra Capital Management first reported a position in BSX in Q2 2019 and has held it in 20 quarters since. The position peaked at $888K in Q1 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Penserra Capital Management held 126 shares of Boston Scientific worth $5K as of Q2 2026.
  • Penserra Capital Management bought 3 Boston Scientific shares in Q2 2026, an estimated $163.
  • Boston Scientific made up ﹤0.01% of Penserra Capital Management's portfolio in Q2 2026, its #952 holding.
  • Penserra Capital Management first reported a position in Boston Scientific in Q2 2019 and has held it in 20 quarters since.
  • Penserra Capital Management's Boston Scientific position peaked at $888K in Q1 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.